Tag
Briumvi
TG Therapeutics raises annual revenue outlook to about US$1B
Adrian Kessler · Nov 9, 2026
TG Therapeutics reports seven-year BRIUMVI disability and safety findings
Adrian Kessler · Oct 21, 2026
TG Therapeutics stock spikes on strong financials and optimism for its flagship drug
Joseph Morton · Mar 3, 2025